5 services found
Burning Rock Biotech Limited Services
-
Genomic Testing
The root cause of tumors can be attributed to the continuous growth of tumor cells. The most important difference between tumor cells and normal cells is that mutant gene (driver gene) that drives tumorigenesis is produced. Therefore, tumors are essentially genetic diseases. Next generation sequencing (NGS) is a high-throughput sequencing method to understand tumors from the gene level, detect and quantify the genetic components that drive tumorigenesis, and then according to the results of testing, targeted drugs and immune drugs can be recommended to patients, prolong the survival time of patients, improve the quality of life, and cure tumors as much as possible.
-
Pan Cancer Services
Cancer is a complicated disease caused by genetic variation. The genetic variation may deprive cells of the normal control function, leading to immortalization and cancer. And targeted drugs work well in cancer therapy, which can kill cancer cells that carry specific genes of variation. However, patients may differ from each other regarding the in vivo genetic variation. As a result, patients vary in the susceptibility and toxic and side effects to the ...
-
Biopharma Partner Sevices
Burning Rock focuses on providing comprehensive cancer genomic solutions for pharmaceutical companies from biomarker discovery to commercialization. Powered by our multi-dimensional genomic data from >250,000* cancer patients in China, multimodal central lab testing, integrated companion diagnostic development and commercialization, as well as precision patient recruitment, Burning Rock facillitates the entire process of anti-cancer drug development.
-
Genomic Data Solutions
Burning Rock utilizes our own proprietary large-scale genomic dataset based on personalized analyses of Chinese cancer patients*, ntegrates the experience from multi-dimensional clinical/scientific research and published data, to provide a one-stop cancer genomic data solution for biopharma partners, aiming to speed up precision drug development and reduce the risks. Burning Rock provides effective biomarker clinical trial strategies for ...
-
Central Lab Testing Services
Burning Rock offers integrated central lab services for biopharma partners, from multimodal sample testing to data analysis, meeting drug developing requirement, with four industry-leading qualifications (CLIA, CAP, NCCL, and NMPA) and full spectra of diagnostic products. So far, we have provided central lab services with >50 clinical research studies for >30 pharmaceutical companies, covering clinical study sites ...
-
CDx Development and Commercialization Services
Burning Rock offers integrated companion diagnostic development services for biopharma partners to streamline the co-development and commercialization of targeted drugs and respective CDx (including registration testing, clinical evaluation and finally obtain registration certificates. Our US-based lab and R&D team provide additional services to promote drug and CDx co-development ...
-
Precision Patient Recruitment Service
Burning Rock proprietary database intelligent screening system screens reports, and regularly identifies patients with rare or specific genetic ...